Ozawa Yu, Sharma Rohan, Moschovas Marcio Covas, Saikali Shady, Gamal Ahmed, Sandri Marco, Rogers Travis, Patel Vipul
AdventHealth Global Robotics Institute, Celebration, FL, USA.
University of Central Florida (UCF), Orlando, FL, USA.
World J Urol. 2025 Sep 3;43(1):536. doi: 10.1007/s00345-025-05749-4.
Perineural invasion (PNI) and lymphovascular invasion (LVI) represent tumor escape mechanisms at radical prostatectomy (RP). We assessed their prognostic significance for biochemical recurrence (BCR) following complete resection.
We analyzed 10,471 men with negative surgical margins after RP, stratified into three groups based on pathological PNI and LVI status: Group 1 (PNI-/LVI-, n = 1,925), Group 2 (PNI+/LVI-, n = 7,849), and Group 3 (LVI+, n = 697; 14 with PNI-/LVI + and 683 with PNI+/LVI+). The cumulative probability of BCR (PSA > 0.2 ng/mL after initial undetectable level), cancer-specific mortality, and all-cause mortality were compared using Kaplan-Meier curves and log-rank tests. Multivariable Cox regression adjusted for age, race, comorbidity, PSA at biopsy, final grade group, pathological T and N stage, and tumor diameter.
The median follow-up was 60 months (IQR: 18-108). Pathological N1 disease was more frequent in Group 3 (5.7%) than in Group 1 (0.1%) and Group 2 (0.3%). Compared with Group 1, the unadjusted hazard ratios (HRs) for BCR were 6.07 (95% CI: 4.30-8.56) in Group 2 and 23.4 (95% CI: 16.3-33.6) in Group 3; adjusted HRs were 2.51 (95% CI: 1.76-3.58) and 3.79 (95% CI: 2.55-5.53), respectively. Mortality outcomes were comparable across groups, both before and after the adjustment.
Our study demonstrated that the combination of PNI and LVI independently predicted BCR following complete resection. Their integration into postoperative risk assessment may improve BCR prediction and guide individualized follow-up planning. Longer follow-up is required to draw definitive conclusions regarding their impact on mortality outcomes.
神经周围浸润(PNI)和淋巴管浸润(LVI)是根治性前列腺切除术(RP)时肿瘤的逃逸机制。我们评估了它们对根治性切除术后生化复发(BCR)的预后意义。
我们分析了10471例RP术后手术切缘阴性的男性患者,根据病理PNI和LVI状态分为三组:第1组(PNI-/LVI-,n = 1925),第2组(PNI+/LVI-,n = 7849),第3组(LVI+,n = 697;14例PNI-/LVI+,683例PNI+/LVI+)。使用Kaplan-Meier曲线和对数秩检验比较BCR(初始不可检测水平后PSA>0.2 ng/mL)、癌症特异性死亡率和全因死亡率的累积概率。多变量Cox回归对年龄、种族、合并症、活检时的PSA、最终分级组、病理T和N分期以及肿瘤直径进行了调整。
中位随访时间为60个月(四分位间距:18 - 108)。第3组中病理N1疾病的发生率(5.7%)高于第1组(0.1%)和第2组(0.3%)。与第1组相比,第2组和第3组未调整的BCR风险比(HR)分别为6.07(95%CI:4.30 - 8.56)和23.4(95%CI:16.3 - 33.6);调整后的HR分别为2.51(95%CI:1.76 - 3.58)和3.79(95%CI:2.55 - 5.53)。调整前后,各组的死亡率结果相当。
我们的研究表明,PNI和LVI共同独立预测根治性切除术后BCR。将它们纳入术后风险评估可能改善BCR预测并指导个体化随访计划。需要更长时间的随访才能就它们对死亡率结果的影响得出明确结论。